Marksans Pharma is a global pharmaceutical company headquartered in Mumbai, India. With a strong focus on research and development (R&D), they offer Contract Research and Manufacturing Services (CRAMS) to pharmaceutical companies worldwide. Their expertise lies in the development and production of both over-the-counter (OTC) and prescription drugs, covering a wide range of applications such as Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, and Gynaecology, among others.

Marksans Pharma has established state-of-the-art manufacturing facilities that adhere to stringent regulatory compliances, earning approvals from prestigious health authorities including the US FDA, UK MHRA, and Australian TGA. With a team of more than 50 experienced scientists, they possess end-to-end capabilities in formulation development and analytical development, ensuring the highest quality standards. Despite being a relatively young company, Marksans Pharma has gained global recognition and has ambitious plans for further expansion in the near future